Rallybio Corporation
RLYB
$0.529
-$0.006-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.40% | 45.44% | 37.60% | 12.85% | -9.88% |
| Total Depreciation and Amortization | -20.00% | -16.67% | -13.51% | -10.53% | -10.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.98% | -17.09% | -9.93% | -4.29% | -17.66% |
| Change in Net Operating Assets | -334.08% | -115.27% | -521.88% | 21.23% | 131.03% |
| Cash from Operations | 33.98% | 15.31% | 17.76% | 22.16% | 17.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.96% | -109.30% | 623.29% | -58.22% | 600.61% |
| Cash from Investing | 7.96% | -109.30% | 623.29% | -58.22% | 600.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -75.34% | -- | 2,507.18% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -25,800.00% | -- |
| Cash from Financing | -- | -75.00% | -- | 2,372.38% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.87% | -313.96% | 164.54% | 62.21% | 70.22% |